Global Glp 1 Receptor Agonists Obesity Drugs Market Market Size in USD Billion GLP-1 Receptor Agonists Obesity Drugs Market Size The global GLP-1 receptor agonists obesity drugs market size was valued at USD 9.96 billion in 2024 and is expected to reach USD 33.12 billion by 2032 , at a CAGR of 16.21% during the forecast period The market growth is primarily driven by the increasing need for secure, transparent, and tamper-proof systems to manage sensitive healthcare data, billing processes, and patient records across diverse stakeholders In addition, the rising adoption of blockchain technology by healthcare providers, insurers, and pharmaceutical companies to streamline operations, enhance data integrity, and mitigate fraud is propelling market expansion
This article does not independently test RxSpan MD products or services, verify individual pharmacy operations, or provide medical, legal, or regulatory advice
New diagnosis rates were highest among women ages 25 to 34 (1.9%) and 18 to 24 (1.7%)
The tip of the N-terminal -helix (T29) moved by 19.9 and inserted into a cleft between TM1 and TM2, partially overlapping with the recently reported allosteric site of PAM LSN3160440 (ref
